View Item 

Show simple item record

YEAR-LONG CLENBUTEROL TREATMENT OF MICE INCREASES MASS, BUT NOT SPECIFIC FORCE OR NORMALIZED POWER, OF SKELETAL MUSCLES

dc.contributor.authorLynch, Gordon S.en_US
dc.contributor.authorHinkle, Richard T.en_US
dc.contributor.authorFaulkner, John A.en_US
dc.date.accessioned2010-06-01T22:30:42Z
dc.date.available2010-06-01T22:30:42Z
dc.date.issued1999-02en_US
dc.identifier.citationLynch, Gordon S; Hinkle, Richard T; Faulkner, John A (1999). "YEAR-LONG CLENBUTEROL TREATMENT OF MICE INCREASES MASS, BUT NOT SPECIFIC FORCE OR NORMALIZED POWER, OF SKELETAL MUSCLES." Clinical and Experimental Pharmacology and Physiology 26(2): 117-120. <http://hdl.handle.net/2027.42/75497>en_US
dc.identifier.issn0305-1870en_US
dc.identifier.issn1440-1681en_US
dc.identifier.urihttps://hdl.handle.net/2027.42/75497
dc.identifier.urihttp://www.ncbi.nlm.nih.gov/sites/entrez?cmd=retrieve&db=pubmed&list_uids=10065331&dopt=citationen_US
dc.format.extent37971 bytes
dc.format.extent3109 bytes
dc.format.mimetypeapplication/pdf
dc.format.mimetypetext/plain
dc.publisherBlackwell Science Ptyen_US
dc.rights1999 Blackwell Science Asia Pty. Ltd.en_US
dc.subject.otherΒ 2 -Adrenoceptor Agonistsen_US
dc.subject.otherClenbuterolen_US
dc.subject.otherContractile Propertiesen_US
dc.subject.otherForceen_US
dc.subject.otherPoweren_US
dc.subject.otherSkeletal Muscleen_US
dc.titleYEAR-LONG CLENBUTEROL TREATMENT OF MICE INCREASES MASS, BUT NOT SPECIFIC FORCE OR NORMALIZED POWER, OF SKELETAL MUSCLESen_US
dc.typeArticleen_US
dc.subject.hlbsecondlevelPharmacy and Pharmacologyen_US
dc.subject.hlbsecondlevelPhysiologyen_US
dc.subject.hlbtoplevelHealth Sciencesen_US
dc.description.peerreviewedPeer Revieweden_US
dc.contributor.affiliationumInstitute of Gerontology and Departments of Physiology and Biomedical Engineering, The University of Michigan, Ann Arbor, Michigan, USAen_US
dc.identifier.pmid10065331en_US
dc.description.bitstreamurlhttp://deepblue.lib.umich.edu/bitstream/2027.42/75497/1/j.1440-1681.1999.03001.x.pdf
dc.identifier.doi10.1046/j.1440-1681.1999.03001.xen_US
dc.identifier.sourceClinical and Experimental Pharmacology and Physiologyen_US
dc.identifier.citedreferenceKim YS & Sainz RD. Β-Adrenergic agonists and hypertrophy of skeletal muscles. Life Sci. 1992; 50: 397 – 407.en_US
dc.identifier.citedreferenceCarter WJ, Dang AQ, Faas FA, Lynch ME. Effects of clenbuterol on skeletal muscle mass, body composition, and recovery from surgical stress in senescent rats. Metabolism 1991; 40: 855 – 60.en_US
dc.identifier.citedreferenceAgbenyega ET & Wareham AC. Effect of clenbuterol on normal and denervated muscle growth and contractility. Muscle Nerve 1990; 13: 199 – 203.en_US
dc.identifier.citedreferenceMaltin CA, Hay SM, Delday MI, Smith FG, Lobley GE, Reeds PJ. Clenbuterol, a beta-agonist, induces growth in innervated and denervated rat soleus muscle via apparently different mechanisms. Biosci. Rep. 1987; 7: 525 – 32.en_US
dc.identifier.citedreferenceZeman RJ, Ludemann R, Etlinger JD. Clenbuterol, a Β 2 -agonist, retards atrophy in denervated muscles. Am. J. Physiol. 1987; 252: E152 – 5.en_US
dc.identifier.citedreferenceDelday MI & Maltin CA. Clenbuterol increases the expression of myogenin but not MyoD in immobilized rat muscles. Am. J. Physiol. 1997; 35: E941 – 4.en_US
dc.identifier.citedreferenceChoo JJ, Horan MA, Little RA, Rothwell NJ. Anabolic effects of clenbuterol on skeletal muscle are mediated by Β 2 -adrenoceptor activation. Am. J. Physiol. 1992; 26: E50 – 6.en_US
dc.identifier.citedreferenceMoore NG, Pegg GG, Sillence MN. Anabolic effects of the Β 2 -adrenoceptor agonist salmeterol are dependent on route of administration. Am. J. Physiol. 1994; 267: E475 – 84.en_US
dc.identifier.citedreferenceMaltin CA, Delday MI, Watson JS et al. Clenbuterol, a Β-adrenoceptor agonist, increases relative muscle strength in orthopaedic patients. Clin. Sci. 1993; 84: 651 – 4.en_US
dc.identifier.citedreferenceZeman RJ, Zhang Y, Etlinger JD. Clenbuterol, a Β 2 -agonist, retards wasting and loss of contractility in irradiated dystrophic mdx muscle. Am. J. Physiol. 1994; 267: C865 – 8.en_US
dc.identifier.citedreferenceJones NL, McCartney N, McComas AJ. Human Muscle Power. Human Kinetics Publishers Inc., Champaign, IL. 1986.en_US
dc.identifier.citedreferenceDupont-Versteegden EE, Katz MS, McCarter RJ. Beneficial versus adverse effects of long-term use of clenbuterol in mdx mice. Muscle Nerve 1995; 18: 1447 – 59.en_US
dc.identifier.citedreference13 National Institutes of Health. Guide for the Care and Use of Laboratory Animals. Office of Science and Health Reports. Public Health Service Publication No. 86-23, Bethesda, MD. 1985.en_US
dc.identifier.citedreferenceYang YT & McElligott MA. Multiple actions of Β 2 -adrenergic agonists on skeletal muscle and adipose tissue. Biochem. J. 1989; 261: 1 – 10.en_US
dc.identifier.citedreferenceHayes A & Williams DA. Long-term clenbuterol administration alters the isometric contractile properties of skeletal muscle from normal and dystrophin-deficient mdx mice. Clin. Exp. Pharm. Physiol. 1994; 21: 757 – 65.en_US
dc.identifier.citedreferenceZeman RJ, Ludemann R, Easton TG, Etlinger JD. Slow to fast alterations in skeletal muscle fibres caused by clenbuterol, a Β 2 -receptor agonist. Am. J. Physiol. 1988; 254: E726 – 32.en_US
dc.identifier.citedreferenceLynch GS, Hayes A, Campbell SP, Williams DA. Effects of Β 2 -agonist administration and exercise on contractile activation of skeletal muscle fibers. J. Appl. Physiol. 1996; 81: 1610 – 18.en_US
dc.identifier.citedreferenceLynch GS, Rafael JA, Hinkle RT et al. Contractile properties of diaphragm muscle segments from old mdx and old transgenic mdx mice. Am. J. Physiol. 1997; 272: C2063 – 8.en_US
dc.identifier.citedreferenceBrooks SV & Faulkner JA. Contractile properties of skeletal muscles from young, adult and aged mice. J. Physiol. 1988; 404: 71 – 82.en_US
dc.identifier.citedreferenceBrooks SV, Faulkner JA, McCubbery DA. Power outputs of slow and fast skeletal muscles of mice. J. App. Physiol. 1990; 68: 1282 – 5.en_US
dc.identifier.citedreferenceMaltin CA, Delday MI, Reeds PJ. The effect of a growth promoting drug, clenbuterol, on fiber frequency and area in hind limb muscles from young male rats. Biosci. Rep. 1986; 6: 293 – 9.en_US
dc.identifier.citedreferenceTorgan CE, Etgen GJ, Kang HY, Ivy JL. Fiber type-specific effects of clenbuterol and exercise training on insulin-resistant muscle. J. Appl. Physiol. 1995; 79: 163 – 7.en_US
dc.identifier.citedreferenceDodd SL, Powers SK, Vrabas I, Criswell D, Stetson S, Hussain R. Effects of clenbuterol on contractile and biochemical properties of skeletal muscle. Med. Sci. Sports Exer. 1996; 28: 669 – 76.en_US
dc.identifier.citedreferenceMurphy RJL, BÉliveau L, Seburn KL, Gardiner PF. Clenbuterol has a greater influence on untrained than on previously trained skeletal muscle in rats. Eur. J. Appl. Physiol. 1996; 73: 304 – 10.en_US
dc.identifier.citedreferenceMacLennan PA & Edwards RHT. Effects of clenbuterol and propranolol on muscle mass. Evidence that clenbuterol stimulates muscle Β-adrenoceptors to induce hypertrophy. Biochem. J. 1989; 264: 573 – 9.en_US
dc.identifier.citedreferencePrather ID, Brown DE, North P, Wilson JR. Clenbuterol: A substitute for anabolic steroids. Med. Sci. Sports Exerc. 1995; 27: 1118 – 21.en_US
dc.identifier.citedreferenceHill AV. The dimensions of animals and their muscular dynamics. Proc R. Inst. Gt Br. 1950; 34: 450 – 71.en_US
dc.owningcollnameInterdisciplinary and Peer-Reviewed


Files in this item

Name:
j.1440-1681.1999.03001.x.pdf
Size:
37.08KB
Format:
PDF
View/Open

Show simple item record

Remediation of Harmful Language

The University of Michigan Library aims to describe library materials in a way that respects the people and communities who create, use, and are represented in our collections. Report harmful or offensive language in catalog records, finding aids, or elsewhere in our collections anonymously through our metadata feedback form. More information at Remediation of Harmful Language.

Accessibility

If you are unable to use this file in its current format, please select the Contact Us link and we can modify it to make it more accessible to you.